Frequency Therapeutics
7 clinical trials · Sponsor
◉ Watch Frequency Therapeutics
| Record | Firm | Date |
|---|---|---|
| First in Human Safety Study of FX-345 in Adults With Sensorineural Hearing Loss (NCT05664100) | Frequency Therapeutics | 2022-12-15 |
| FX-322 in Adults With Severe Sensorineural Hearing Loss (NCT04629664) | Frequency Therapeutics | 2020-11-02 |
| FX-322 in Adults With Age-Related Sensorineural Hearing Loss (NCT04601909) | Frequency Therapeutics | 2020-09-17 |
| FX-322 in Adults With Stable Sensorineural Hearing Loss (NCT04120116) | Frequency Therapeutics | 2019-10-04 |
| FX-322 in Sensorineural Hearing Loss (NCT03616223) | Frequency Therapeutics | 2018-07-03 |
Track Frequency Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.